Total Payments
$6,195
2024 Payments
$1,086
Companies
30
Transactions
356
Medicare Patients
6,808
Medicare Billing
$705,649
Payment Breakdown by Category
Food & Beverage$6,195 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,195 | 356 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,138 | 77 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $813.25 | 67 | $0 (2024) |
| Merck Sharp & Dohme LLC | $566.69 | 33 | $0 (2024) |
| PFIZER INC. | $509.35 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $449.63 | 19 | $0 (2024) |
| Boston Scientific Corporation | $370.01 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $352.06 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $238.73 | 12 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $200.29 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $198.72 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,086 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($196.65) |
| 2023 | $1,745 | 89 | Novartis Pharmaceuticals Corporation ($325.77) |
| 2022 | $453.67 | 21 | Novartis Pharmaceuticals Corporation ($93.00) |
| 2021 | $703.69 | 55 | Novartis Pharmaceuticals Corporation ($184.43) |
| 2020 | $318.30 | 23 | Novartis Pharmaceuticals Corporation ($114.93) |
| 2019 | $524.06 | 41 | Janssen Pharmaceuticals, Inc ($181.82) |
| 2018 | $666.11 | 41 | Janssen Pharmaceuticals, Inc ($173.85) |
| 2017 | $698.86 | 34 | BOSTON SCIENTIFIC CORPORATION ($224.98) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: DEVICES | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Obesity | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Genetic Disease | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: DIABETES | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $48.14 | General |
| 05/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Obesity | ||||||
| 05/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,950 | 2,472 | $423,880 | $129,631 |
| 2022 | 10 | 305 | 339 | $61,871 | $21,250 |
| 2021 | 21 | 2,153 | 4,817 | $1.0M | $281,785 |
| 2020 | 22 | 2,400 | 5,236 | $1.1M | $272,983 |
Total Patients
6,808
Total Services
12,864
Medicare Billing
$705,649
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 231 | 465 | $98,209 | $41,476 | 42.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 150 | 157 | $77,715 | $21,470 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 100 | $40,700 | $12,933 | 31.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 83 | 83 | $33,150 | $12,336 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 58 | $16,563 | $6,504 | 39.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 124 | 127 | $22,606 | $6,143 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 99 | $14,751 | $5,871 | 39.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 88 | 88 | $30,448 | $4,932 | 16.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $19,780 | $4,148 | 21.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 269 | 382 | $24,860 | $3,860 | 15.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 476 | 564 | $21,216 | $3,244 | 15.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,964 | $1,329 | 33.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 88 | 88 | $5,720 | $904.36 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $1,872 | $881.92 | 47.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 38 | 43 | $1,266 | $753.03 | 59.5% |
| 75710 | Review by radiologist of arm or leg artery image | Facility | 2023 | 11 | 11 | $2,002 | $686.29 | 34.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 11 | 12 | $3,720 | $652.50 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 77 | $883.00 | $646.80 | 73.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 17 | $935.00 | $286.24 | 30.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 13 | 13 | $871.00 | $228.71 | 26.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 24 | 24 | $2,088 | $219.05 | 10.5% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 17 | $561.00 | $126.03 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 80 | $16,662 | $7,676 | 46.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 26 | 26 | $13,830 | $3,921 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $6,384 | $2,696 | 42.2% |
About Dr. Jaideep Debsikdar, M.D
Dr. Jaideep Debsikdar, M.D is a Internal Medicine healthcare provider based in Sumter, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558308452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaideep Debsikdar, M.D has received a total of $6,195 in payments from pharmaceutical and medical device companies, with $1,086 received in 2024. These payments were reported across 356 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,195).
As a Medicare-enrolled provider, Debsikdar has provided services to 6,808 Medicare beneficiaries, totaling 12,864 services with total Medicare billing of $705,649. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Sumter, SC
- Active Since 05/31/2006
- Last Updated 08/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558308452
Products in Payments
- ENTRESTO (Drug) $856.92
- XARELTO (Drug) $826.83
- VERQUVO (Drug) $566.69
- JARDIANCE (Drug) $449.63
- ELIQUIS (Drug) $391.26
- LifeVest (Device) $352.06
- LEQVIO (Drug) $280.94
- VYNDAQEL (Drug) $215.06
- ONPATTRO (Drug) $200.29
- Repatha (Biological) $151.20
- MULTAQ (Drug) $132.10
- ACCOLADE (Device) $123.35
- FARXIGA (Drug) $112.16
- WATCHMAN DEVICE (Device) $101.63
- FUROSCIX (Drug) $94.23
- CAMZYOS (Drug) $83.71
- Advisa (Device) $79.51
- (5044) MCOT (Device) $76.93
- LUX-Dx Insertable Cardiac Monitor (Device) $72.73
- BRILINTA (Drug) $72.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sumter
Moinuddin Syed
Internal Medicine — Payments: $14,428
Internal Medicine $14,428
James Altman, M.d, M.D
Internal Medicine — Payments: $10,957
Internal Medicine $10,957
Harry Jordan, M.d, M.D
Internal Medicine — Payments: $8,397
Internal Medicine $8,397
Dr. Andrew Reynolds, Md, MD
Internal Medicine — Payments: $8,018
Internal Medicine $8,018
Dr. Thomas Hawkey, D.o, D.O
Internal Medicine — Payments: $6,547
Internal Medicine $6,547
Dr. Hugh Stoddard, Md, MD
Internal Medicine — Payments: $3,466
Internal Medicine $3,466